Neonc Technologies Holdings, Inc.

NASDAQ:NTHI

Biotechnology

Healthcare
$4.16 +2.94%

+$0.14 today

Market cap
$120.02M
Beta
0.29
P/E (TTM)
-3.0
EPS (TTM)
-$1.66
52W Low $3.20High $12.99

Volume 0.27M

Average 0.08M

Income Statement

Follow revenue through to earnings.

Revenue

$39,990.00

FY 2025 · Annual

Operating Income

-$58.17M

FY 2025 · Annual

Net Income

-$62.15M

FY 2025 · Annual

NTHI Earnings Waterfall · TTM

NASDAQ:NTHI · Revenue to Net Income

Key Ratios

EPS$-1.94
Gross Margin0.0%
Net Margin0.0%
P/E Ratio-3.8
P/S Ratio0.0

Analysis

$0 of revenue converted into -$38.6M of net income for the selected period. Gross margin is 0.0% and net margin is 0.0%, showing how much revenue survives after costs and taxes. EPS is $-1.94, tying the income statement back to per-share earnings.

Competitors

Peer companies in the same sector

Health

No competitor data available.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
8-KCurrent reportNov 13, 2026
4Statement of changes in beneficial ownershipNov 13, 2026
4Statement of changes in beneficial ownershipNov 12, 2026
4Statement of changes in beneficial ownershipNov 12, 2026
4Statement of changes in beneficial ownershipNov 9, 2026

How much revenue does NTHI generate?

Neonc Technologies Holdings, Inc. (NTHI) reported $39,990.00 of revenue in fiscal 2025.

Is NTHI profitable?

Neonc Technologies Holdings, Inc. (NTHI) reported -$62.15M of net income, with a net margin of -155404.4%.